About this trial
The study is sponsored by the National Heart, Lung, and Blood Institute, which is part of the National Institutes of Health. The study expects to enroll 400 subjects. The research team will recruit research participants that are finishing or will finish cardiac rehabilitation soon. Participants belong to one or more groups of people who are less often studied in cardiac rehabilitation research, may have less access to a formal cardiac rehabilitation maintenance program, or they may especially benefit from additional support after cardiac rehabilitation ends. The main purposes of this study are to evaluate which treatments work the best after cardiac rehabilitation, which order to deliver the treatments in, and which treatments are as minimally burdensome as possible while still working well. This study will make two comparisons (one comparison between a set of low-intensity interventions and another between a set of higher-intensity interventions) to determine which produces the best behavioral adherence immediately after Phase II (outpatient) cardiac rehabilitation
Eligibility criteria
Qualifiers
≥18 years of age or older
Have completed at least 6 CR sessions
Must enroll within 6 weeks of their final CR session
BMI ≥27
Disqualifiers
New York Heart Association Class IV heart failure
Heart transplant in the last 5 months
Left ventricular assist device in the last 4 months
Physician diagnosis of dementia
Trial design
Treatments tested in this trial
- Text Messaging
- Fully Automated Online Program
- Low-Intensity Cardiac Rehabilitation Maintenance Program
- High Intensity Cardiac Rehabilitation Maintenance Program
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
The Miriam Hospital
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Office of the Director, National Institutes of Health (OD)
Collaborator